YAP1 and esophageal cancer: Moreover, verteporfin, a YAP1 inhibitor, promotes sensitivity to 5-fluorouracil and docetaxel by directly inhibiting YAP1 and endothelial growth factor receptor in esophageal cancer cells [21].